ArticleMed (New York, N.Y.)2026

N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy.

Margot A Cousin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.